The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
Open accessAbstract
BACKGROUND: In observational studies, lower homocysteine levels are associated with lower rates of coronary heart disease and stroke. Folic acid and vitamins B6 and B12 lower homocysteine levels. We assessed whether supplementation reduced the risk of major cardiovascular events in patients with vascular disease. METHODS: We randomly assigned 5522 patients 55 years of age or older who had vascular disease or diabetes to daily treatment either with the combination of 2.5 mg of folic acid, 50 mg of vitamin B6, and 1 mg of vitamin B12 or with placebo for an average of five years. The primary outcome was a composite of death from cardiovascular causes, myocardial infarction, and stroke. RESULTS: Mean plasma homocysteine levels decreased by 2.4 micromol per liter (0.3 mg per liter) in the active-treatment group and increased by 0.8 micromol per liter (0.1 mg per liter) in the placebo group. Primary outcome events occurred in 519 patients (18.8 percent) assigned to active therapy and 547 (19.8 percent) assigned to placebo (relative risk, 0.95; 95 percent confidence interval, 0.84 to 1.07; P=0.41). As compared with placebo, active treatment did not significantly decrease the risk of death from cardiovascular causes (relative risk, 0.96; 95 percent confidence interval, 0.81 to 1.13), myocardial infarction (relative risk, 0.98; 95 percent confidence interval, 0.85 to 1.14), or any of the secondary outcomes. Fewer patients assigned to active treatment than to placebo had a stroke (relative risk, 0.75; 95 percent confidence interval, 0.59 to 0.97). More patients in the active-treatment group were hospitalized for unstable angina (relative risk, 1.24; 95 percent confidence interval, 1.04 to 1.49). CONCLUSIONS: Supplements combining folic acid and vitamins B6 and B12 did not reduce the risk of major cardiovascular events in patients with vascular disease. (ClinicalTrials.gov number, NCT00106886; Current Controlled Trials number, ISRCTN14017017.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Antman, E. M., Bassand, J., Klein, W. W., Ohman, M. E., Sendón, J. L. L., Rydén, L., Simoons, M. L., & Tendera, M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00804-4 · Cited by 4,824
A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,708
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis
Wald, D. S., Law, M., & Morris, J. K. (2002) · BMJ · doi:10.1136/bmj.325.7374.1202 · Cited by 1,945
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442
Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C.-H., & Stampfer, M. (2004) · JAMA · doi:10.1001/jama.291.5.565 · Cited by 1,391
Vivekananthan, D. P., Penn, M. S., Sapp, S. K., Hsu, A., & Topol, E. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13637-9 · Cited by 1,083
MTHFR 677C→T Polymorphism and Risk of Coronary Heart Disease
Klerk, M., Verhoef, P., Clarke, R., Blom, H. J., Kok, F. J., & Schouten, E. G. (2002) · JAMA · doi:10.1001/jama.288.16.2023 · Cited by 932
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,000
Elevated Homocysteine Is Associated With Reduced Regional Left Ventricular Function
Nasir, K., Tsai, M. Y., Rosen, B. D., Fernandes, V., Bluemke, D. A., Folsom, A. R., & Lima, J. A. C. (2007) · Circulation · doi:10.1161/circulationaha.106.633750 · Cited by 57
Ndounga‐Diakou, L. A., Trinquart, L., Hróbjartsson, A., Barnes, C., Yavchitz, A., Ravaud, P., & Boutron, I. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000043.pub2 · Cited by 57
Homocysteine lowering and cardiovascular disease risk: Lost in translation
Marcus, J. S., Sarnak, M. J., Menon, V., & Verma, S. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)70814-0 · Cited by 57
Novel markers of peripheral arterial disease
Khawaja, F. J., & Kullo, I. J. (2009) · Vascular Medicine · doi:10.1177/1358863x09106869 · Cited by 57
Yang, Q., Bailey, L. B., Clarke, R., Flanders, W. D., Liu, T., Yesupriya, A., Khoury, M. J., & Friedman, J. M. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.022384 · Cited by 57
Hyperhomocysteinemia and Venous Thrombosis
Gatt, A., & Makris, M. (2007) · Seminars in Hematology · doi:10.1053/j.seminhematol.2007.01.002 · Cited by 58
Environmental mechanisms of orofacial clefts
Garland, M. A., Reynolds, K., & Zhou, C. J. (2020) · Birth Defects Research · doi:10.1002/bdr2.1830 · Cited by 65
“Folate deficiency could additionally result in the accumulation of homocysteine to toxic levels (hyperhomocysteinemia), which has been linked to OFCs (Lonn et al., 2006; Wong et al., 1999).”
BackgroundMei, W., Rong, Y., Jinming, L., Li, Y., & Hu, Z. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02207.x · Cited by 56
Age, Homocysteine, and Oxidative Stress: Relation to Hypertension and Type 2 Diabetes Mellitus
Dominguez, L. J., Galioto, A., Pineo, A., Ferlisi, A., Ciaccio, M., Putignano, E., Belvedere, M., Costanza, G., & Barbagallo, M. (2010) · Journal of the American College of Nutrition · doi:10.1080/07315724.2010.10719810 · Cited by 55
Hyperhomocysteinaemia and poor vitamin B status in chronic obstructive pulmonary disease
Fimognari, F. L., Loffredo, L., Simone, S. D., Sampietro, F., Pastorelli, R., Monaldo, M., Violi, F., & D’Angelo, A. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.12.006 · Cited by 58
Cobalamin deficiency, hyperhomocysteinemia, and dementia
Werder (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6564 · Cited by 57
Cardiovascular risk in patients with rheumatoid arthritis
Lauper, K., & Gabay, C. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0632-2 · Cited by 62
Bleie, Ø., Semb, A. G., Grundt, H., Nordrehaug, J. E., Vollset, S. E., Ueland, P. M., Nilsen, D. W. T., Bakken, A. M., Refsum, H., & Nygard, O. K. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01810.x · Cited by 55
Therapeutic RNA-silencing oligonucleotides in metabolic diseases
Goga, A., & Stoffel, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00407-5 · Cited by 58
Evans, M., Rumberger, J. A., Azumano, I., Napolitano, J. J., Citrolo, D., & Kamiya, T. (2014) · Vascular Health and Risk Management · doi:10.2147/vhrm.s57116 · Cited by 56
Stopper, H., Treutlein, A.-T., Bahner, U., Schupp, N., Schmid, U., Brink, A., Perna, A. F., & Heidland, A. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn254 · Cited by 56
Chi, Y., & Jaff, M. R. (2008) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.21401 · Cited by 55
Cacciapuoti, F. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-012-0856-x · Cited by 55
Tu, W., Zhao, S., Liu, T., Yang, D., & Chen, H. (2013) · Neurological Research · doi:10.1179/1743132813y.0000000228 · Cited by 56
Meta-analysis of cancer risk in folic acid supplementation trials
Baggott, J. E., Oster, R. A., & Tamura, T. (2011) · Cancer Epidemiology · doi:10.1016/j.canep.2011.05.003 · Cited by 54
Hsu, C., Chiu, S., Hong, K., Saver, J. L., Wu, Y., Lee, J.-D., Lee, M., & Ovbiagele, B. (2018) · Journal of Stroke · doi:10.5853/jos.2017.01522 · Cited by 55
B vitamins for stroke prevention
Hankey, G. J. (2018) · Stroke and Vascular Neurology · doi:10.1136/svn-2018-000156 · Cited by 54
“► The Heart Outcomes Protection Evaluation-2 (HOPE-2) trial 37 re-ported that B vitamins reduced the risk of stroke by 23%, and it is hypothesised that this was because the trial included a younger study population with better renal function than other trials such as Norwegian Vitamin (NORVIT) 36…”
ResultThe Role of Paraoxonase 1 in the Detoxification of Homocysteine Thiolactone
Jakubowski, H. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-60761-350-3_11 · Cited by 53
Vascular risk factors in South Asians
Τζιόμαλος, Κ., Weerasinghe, C., Mikhailidis, D. P., & Seifalian, A. M. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.11.059 · Cited by 53
“Elevated plasma homocysteine levels might also represent an independent risk factor for CHD [129,130] but homocysteine-lowering treatment did not improve outcome in patients with established CVD [131,132].”
BackgroundDo Dietary Supplements Have Beneficial Health Effects in Industrialized Nations
Marik, P. E., & Flemmer, M. C. (2012) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607111416485 · Cited by 57
Liampas, I., Siokas, V., Mentis, A. A., Aloizou, A., Dastamani, M., Tsouris, Z., Aslanidou, P., Brotis, A. G., & Dardiotis, E. (2020) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13892 · Cited by 55
Homocysteine lowering and cardiovascular events after acute myocardial infarction
Watson, K. E. (2007) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-007-0015-7 · Cited by 54
“Recently, the Heart Outcomes Prevention Evaluation (HOPE) 2 trial [3] reported very similar findings.”
ResultChang, J. Y., Wang, Y., Wu, Y., Cheng, S., Chen, H., & Sun, A. (2015) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2015.06.006 · Cited by 53
“The high blood homocysteine level in patients is found to be attributable to deficiencies in folic acid, vitamin B12, and vitamin B6, because a supplement therapy with folic acid, vitamin B12, and vitamin B6 to patients can reduce blood homocysteine levels.(15,16,23) In this study, all 64 patients with abnormally high…”
BackgroundQuo Vadis: Whither Homocysteine Research?
Joseph, J., Handy, D. E., & Loscalzo, J. (2009) · Cardiovascular Toxicology · doi:10.1007/s12012-009-9042-6 · Cited by 53
The CBS/CSE system: a potential therapeutic target in NAFLD?
Sarna, L. K., Siow, Y. L., & Karmin, O. (2014) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0394 · Cited by 54
“Although not recognized as a causative factor, homocysteine remains a biomarker of increased risk of cardiovascular morbidity and mortality (Lonn et al. 2006; Loscalzo 2006).”
BackgroundTuran, A., Mascha, E. J., You, J., Kurz, A. M., Shiba, A., Saager, L., & Sessler, D. I. (2012) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31824590a5 · Cited by 52
Chang, J. Y., Wang, Y., Wu, Y., Wu, Y.-H., Tseng, C.-H., & Sun, A. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.07.006 · Cited by 52
Hyperhomocysteinemia and Cardiovascular Risk: Effect of Vitamin Supplementation in Risk Reduction
Ciaccio, M., & Bellia, C. (2010) · Current Clinical Pharmacology · doi:10.2174/157488410790410551 · Cited by 54
Næss, I. A., Christiansen, S. C., Romundstad, P., Cannegieter, S. C., Blom, H. J., Rosendaal, F. R., & Hammerstrøm, J. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07073.x · Cited by 52
Homocysteine and Hypertension in Diabetes: Does PPAR γ Have a Regulatory Role?
Sen, U., & Tyagi, S. C. (2010) · PPAR Research · doi:10.1155/2010/806538 · Cited by 52
Coronary Heart Disease in Women: Update 2008
WENGER, N. K., Shaw, L. J., & Vaccarino, V. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100447 · Cited by 52
Binia, A., Contreras, A. V., Canizales‐Quinteros, S., Acuña-Alonzo, V., Tejero, M. E., & Silva‐Zolezzi, I. (2014) · Genes & Nutrition · doi:10.1007/s12263-014-0421-7 · Cited by 53
“…supplementation in reducing the risk for cardiovascular diseases (CVD) by decreasing the homocysteine levels is not clear, revealing a more complex relationship between vitamin intake levels, homocysteine and CVD (Bonaa et al. 2006; Homocysteine Studies 2002; Toole et al. 2004; Lonn et al. 2006).”
BackgroundDanshensu protects vascular endothelia in a rat model of hyperhomocysteinemia
Yang, R.-X., Huang, S.-Y., Yan, F., Lu, X., Xing, Y., Liu, Y., Yun-fang, L., & Zhao, Y. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.167 · Cited by 52
Meta-analysis of folic acid efficacy trials in stroke prevention
Zhao, M., Wu, G., Li, Y., Wang, X., Hou, F. F., Xu, X., Qin, X., & Cai, Y. (2017) · Neurology · doi:10.1212/wnl.0000000000003909 · Cited by 52
Lin, H., Wu, Y.-H., Wang, Y., Wu, Y., Chang, J. Y., & Sun, A. (2017) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2017.02.001 · Cited by 51
“Notably, there were no significant differences in mean serum vitamin B12 and homocysteine levels between 210 GPCA / microcytosis or 240 microcytosis patients and 240 healthy controls; however, the 30 GPCAþ/microcytosis patients had lower mean vitamin B12 level (marginal significance) and significantly higher mean seru…”
BackgroundRole of homocysteine in end-stage renal disease
Wu, C., Zheng, C., Lin, Y., Lo, L., Liao, M.-T., & Lu, K. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.05.031 · Cited by 51
“The Heart Outcomes Prevention Evaluation (HOPE)-2 study reported that combined treatment with folic acid and vitamins B6 and B12 in patients with vascular disease or diabetes showed no effect on cardiovascular outcomes [66].”
MethodWang, C., Chen, Z., Zhang, T., Liu, J., Chen, S., Liu, S.-Y., Han, L., Hui, Z., & Chen, Y. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.04.011 · Cited by 51
“The current data state that there is a positive association between total homocysteine (tHcy) and risk of hypertension [2,3], ischemic stroke (IS) [4–11] and coronary heart disease (CHD) [4,11–14], but interventional trials with folate supplementation have so far failed to verify the association [15].”
BackgroundPredictors of Vitamin B6 and Folate Concentrations in Older Persons: The InCHIANTI Study
Gori, A. M., Sofi, F., Corsi, A. M., Gazzini, A., Sestini, I., Lauretani, F., Bandinelli, S., Gensini, G. F., Ferrucci, L., & Abbate, R. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.066217 · Cited by 51
Hydrogen sulfide in the pathogenesis of atherosclerosis and its therapeutic potential
Lynn, E. G., & Austin, R. C. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.130 · Cited by 51
Enkhmaa, B., Surampudi, P. N., Anuurad, E., & Berglund, L. (2015) · Europe PMC (PubMed Central) · Cited by 50
Homocysteine lowering for stroke prevention: Unravelling the complexity of the evidence
Spence, J. D. (2016) · International Journal of Stroke · doi:10.1177/1747493016662038 · Cited by 50
Biochemistry of Fat Soluble Vitamins, Sources, Biochemical Functions and Toxicity
Rafeeq, H., Ahmad, S., Tareen, M. B. K., Shahzad, K. A., Bashir, A., Jabeen, R., Tariq, S., & Shehzadi, I. (2020) · Haya The Saudi Journal of Life Sciences · doi:10.36348/sjls.2020.v05i09.007 · Cited by 60
Consequences of dietary methyl donor supplements: Is more always better?
Shorter, K. R., Felder, M. R., & Vrana, P. B. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2015.03.007 · Cited by 51
Lin, H., Wu, Y., Wang, Y., Wu, Y., Chang, J. Y., & Sun, A. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.10.006 · Cited by 50
Dietary and supplementary betaine: Effects on betaine and homocysteine concentrations in males
Atkinson, W., Slow, S., Elmslie, J. L., Lever, M., Chambers, S. T., & George, P. M. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.01.004 · Cited by 50
Nutritional Supplements for Older Adults: Review and Recommendations—Part I
Buhr, G. T., & Bales, C. W. (2009) · Journal of Nutrition for the Elderly · doi:10.1080/01639360802640545 · Cited by 50
Folic acid improves vascular reactivity in humans: a meta-analysis of randomized controlled trials
de Bree, A., van Mierlo, L. A. J., & Draijer, R. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.610 · Cited by 51
Are dietary choline and betaine intakes determinants of total homocysteine concentration?
Lee, J. E., Jacques, P. F., Dougherty, L., Selhub, J., Giovannucci, E. L., Zeisel, S. H., & Cho, E. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28456 · Cited by 50
Folic Acid Supplementation for Stroke Prevention in Patients With Cardiovascular Disease
Tian, T., Yang, K., Cui, J., Zhou, L., & Zhou, X. (2017) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2017.05.020 · Cited by 51
Chen, L., Li, Q., Fang, X., Wang, X., Min, J., & Wang, F. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa061 · Cited by 51
Pizzolo, F., Blom, H. J., Choi, S., Girelli, D., Guarini, P., Martinelli, N., Stanzial, A. M., Corrocher, R., Olivieri, O., & Friso, S. (2011) · Journal of the American College of Nutrition · doi:10.1080/07315724.2011.10719939 · Cited by 51
Randomized Clinical Trial of Homocysteine Level–Lowering Therapy and Fractures
Sawka, A. M., Ray, J. G., Yi, Q., Josse, R. G., & Lonn, E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.19.2136 · Cited by 47
Agarwala, A., Satish, P., Rifai, M. A., Mehta, A., Cainzos‐Achirica, M., Shah, N. S., Kanaya, A. M., Sharma, G. V., Dixon, D. L., Blumenthal, R. S., et al. (2023) · JACC Advances · doi:10.1016/j.jacadv.2023.100258 · Cited by 52
“178,179 The association of tumor necrosis factor-α , leptin, and adiponectin with cardiovascular risk among SAs remains to be studied.”
BackgroundDebreceni, B., & Debreceni, L. (2011) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00266.x · Cited by 51
Cornish, M. L., Critchley, A. T., & Mouritsen, O. G. (2015) · Phycologia · doi:10.2216/15-77.1 · Cited by 49
Role of TheMTHFRPolymorphisms in Cancer Risk Modification and Treatment
Kim, Y. (2009) · Future Oncology · doi:10.2217/fon.09.26 · Cited by 49
Guelpen, B. R. V., Hultdin, J., Johansson, I., Witthöft, C. M., Weinehall, L., Eliasson, M., Hallmans, G., Palmqvist, R., Jansson, J., & Winkvist, A. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02077.x · Cited by 49
Unraveling the complex relationship between folate and cancer risk
Mason, J. B. (2011) · BioFactors · doi:10.1002/biof.174 · Cited by 49
Meta‐analysis: folic acid in the chemoprevention of colorectal adenomas and colorectal cancer
Carroll, C., Cooper, K. L., Papaioannou, D. E., Hind, D., Tappenden, P., Pilgrim, H., & Booth, A. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04238.x · Cited by 49
Evidence-Based Cardiology in Hemodialysis Patients
Allon, M. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013060632 · Cited by 52
Homocystine Levels, Polymorphisms and the Risk of Ischemic Stroke in Young Asian Indians
Biswas, A., Ranjan, R., Meena, A., Akhter, M. S., Yadav, B. K., Munisamy, M., Subbiah, V., Behari, M., & Saxena, R. (2009) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2008.09.014 · Cited by 49
Okumura, K., & Tsukamoto, H. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.01.003 · Cited by 50
Koyama, K., Ito, A., Yamamoto, J., Nishio, T., Kajikuri, J., Dohi, Y., Ohte, N., Sano, A., Nakamura, H., Kumagai, H., et al. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.12.035 · Cited by 47
Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease
Liao, D., Yang, X., & Wang, H. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.358 · Cited by 49
Folate, Vitamin B6, Vitamin B12, and Methionine Intakes and Risk of Stroke Subtypes in Male Smokers
Larsson, S. C., Männistö, S., Virtanen, M. J., Kontto, J. P., Albanes, D., & Virtamo, J. R. K. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwm395 · Cited by 48
Undas, A., Stïpień, E., Głowacki, R., Tisończyk, J., Tracz, W., & Jakubowski, H. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-04-0228 · Cited by 46
Diabetes and cardiometabolic risk in South Asian youth: A review
Wolf, R. M., Nagpal, M., & Magge, S. N. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13078 · Cited by 61
High‐ but not low‐dose folic acid improves endothelial function in coronary artery disease
Moat, S. J., Madhavan, A., Taylor, S., Payne, N., Allen, R. H., Stabler, S. P., Goodfellow, J., McDowell, I. F. W., LEWIS, M. J., & Lang, D. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01739.x · Cited by 47
Role of homocysteine in aortic calcification and osteogenic cell differentiation
Campenhout, A. V., Moran, C. S., Parr, A., Clancy, P., Rush, C. M., Jakubowski, H., & Golledge, J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.031 · Cited by 47
Xiao, Y., Huang, W. H., Zhang, J., Peng, C., Xia, M., & Ling, W. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303817 · Cited by 47
Zawada, A. M., Rogacev, K. S., Hummel, B., Grün, O. S., Friedrich, A., Rotter, B., Winter, P., Geisel, J., Fliser, D., & Heine, G. H. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.112.963207 · Cited by 47
The effect of folic acid in patients with cardiovascular disease
Wang, Y., Yang, J., Wang, Y., Li, L., Liao, Y., Zhang, Y., & Yu, D. S. (2019) · Medicine · doi:10.1097/md.0000000000017095 · Cited by 50
Chiang, C., Wu, Y.-H., Wu, Y., Chang, J. Y., Wang, Y., & Sun, A. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2019.10.013 · Cited by 47
Obeid, R., Kirsch, S. H., Kasoha, M., Eckert, R., & Herrmann, W. (2010) · Metabolism · doi:10.1016/j.metabol.2010.06.020 · Cited by 47
“Supplementation with FA was positively associated with cancer risk in some [20] but not all studies [21,22].”
BackgroundNtaios, G., Savopoulos, C. G., Karamitsos, D. T., Economou, I., Destanis, E., Chryssogonidis, I., Pidonia, I., Zebekakis, P. E., Polatides, C., Sion, M. L., et al. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.01.023 · Cited by 47
Management of peripheral arterial disease patients: comparing the ACC/AHA and TASC-II guidelines
Mohler, E. R., & Giri, J. S. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802274379 · Cited by 48
Screening Strategies for Cardiovascular Disease in Asymptomatic Adults
Wallace, M., Ricco, J. A., & Barrett, B. P. (2014) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2014.02.010 · Cited by 47
Cianciolo, G., Manna, G. L., Colì, L., Donati, G., D’Addio, F., Persici, E., Comai, G., Wratten, M. L., Dormi, A., Mantovani, V., et al. (2008) · American Journal of Nephrology · doi:10.1159/000142363 · Cited by 45
Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort
Ardoin, S. P., Schanberg, L. E., Sandborg, C. I., Yow, E. S., Barnhart, H., Mieszkalski, K. L., Ilowite, N. T., von Scheven, E., Eberhard, A., Levy, D. M., et al. (2010) · Lupus · doi:10.1177/0961203310373937 · Cited by 46
Eilat-Adar, S., & Goldbourt, U. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.01.011 · Cited by 46
“Heart outcomes Prevention Evaluation (HOPE) 2 [42] 2.”
Backgroundde Vogel, S., Meyer, K., Fredriksen, A., Ulvik, A., Ueland, P. M., Nygard, O. K., Vollset, S. E., Tell, G. S., Tretli, S., & Bjørge, T. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys199 · Cited by 45
Xiao, Y., Zhang, Y., Lv, X., Su, D., Li, D., Xia, M., Qiu, J., Ling, W., & Ma, J. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-137 · Cited by 46
Anderson, J. A. M., & Weitz, J. I. (2010) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2010.07.004 · Cited by 46
Chatterjee, K., Fall, S., & Barer, D. H. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-125 · Cited by 46
Micronutrients and Older Adults
Marian, M. J., & Sacks, G. S. (2009) · Nutrition in Clinical Practice · doi:10.1177/0884533609332177 · Cited by 46
Luger, M., Holstein, B., Schindler, K., Kruschitz, R., & Ludvik, B. (2013) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0033-1341472 · Cited by 45
Non-pharmacologic prevention of Alzheimer’s disease: nutritional and life-style risk factors
Weih, M., Wiltfang, J., & Kornhuber, J. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0704-x · Cited by 49
“Recent interventional trials for cardiovascular outcomes (recurrent myocardial infarction, stroke and vascular death) consistently showed no benefit for lowering Homocysteine with vitamin B (Bonaa et al., 2006; Lonn et al., 2006; Toole et al., 2004).”
BackgroundEndothelial Function in Newborn Infants Is Related to Folate Levels and Birth Weight
Martin, H., Lindblad, B. S., & Norman, M. (2007) · PEDIATRICS · doi:10.1542/peds.2006-2706 · Cited by 45
Zappacosta, B., Graziano, M., Persichilli, S., Castelnuovo, A. F. D., Mastroiacovo, P., & Iacoviello, L. (2013) · Cell Biochemistry and Function · doi:10.1002/cbf.3019 · Cited by 45
Adropin is associated with hyperhomocysteine and coronary atherosclerosis
Zhao, L., You, T., Chan, S., Chen, J.-C., & Xu, W. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2954 · Cited by 44
L-DOPA-induced hyperhomocysteinemia in Parkinson's disease: Elephant in the room
Paul, R. K., & Borah, A. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.06.018 · Cited by 45
Sipkens, J. A., Krijnen, P. A. J., Meischl, C., Cillessen, S. A. G. M., Smulders, Y. M., Smith, D. E. C., Giroth, C., Spreeuwenberg, M. D., Musters, R. J. P., Muller, A., et al. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0077-5 · Cited by 44
Chou, Y., Lee, M., Wu, M.-H., Shih, H.-L., Yang, T., Yu, C., Yu, J., & Sun, C. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9278-9 · Cited by 46
Plasma vitamin B12 concentrations and the risk of colorectal cancer: A nested case‐referent study
Dahlin, A. M., Guelpen, B. R. V., Hultdin, J., Johansson, I., Hallmans, G., & Palmqvist, R. (2007) · International Journal of Cancer · doi:10.1002/ijc.23299 · Cited by 44
PROGRESS IN UREMIC TOXIN RESEARCH: Hyperhomocysteinemia in Uremia—A Red Flag in a Disrupted Circuit
Perna, A. F., Ingrosso, D., Violetti, E., Luciano, M. G., Sepe, I., Lanza, D., Capasso, R., Ascione, E., Raiola, I., Lombardi, C., et al. (2009) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2009.00579.x · Cited by 44
Metadata
- Authors
- The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators
- Affiliations
- Hamilton General Hospital (CA)
- Corresponding author
- The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-04-13
- Volume
- 354
- Issue
- 15
- Pages
- 1567-1577
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2109544293
- Cited by
- 1,729
- References
- 20
- Citations by year
- 2026: 43 · 2025: 46 · 2024: 33 · 2023: 30 · 2022: 43 · 2021: 37 · 2020: 52 · 2019: 46 · 2018: 46 · 2017: 70 · 2016: 81 · 2015: 77 · 2014: 84 · 2013: 85 · 2012: 104
- FWCI
- 136.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pittsburgh
- Massachusetts Medical Society
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- homocysteine lowering, folic acid, vitamin B6, vitamin B12, vascular disease, cardiovascular events, stroke, myocardial infarction, cardiovascular mortality, unstable angina, diabetes mellitus, older adults
- MeSH terms
- Aged, Cardiovascular Diseases, Diabetes Mellitus, Double-Blind Method, Drug Therapy, Combination, Female, Folic Acid, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Risk Factors, Vascular Diseases, Vitamin B 12, Hyperhomocysteinemia, Stroke, Vitamin B 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
